1 enrolling by invitation, 1 recruiting. .
Follow Douglas Scharre: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Integrating eSAGE With EHR Data Using Machine Learning for the Early Detection and Monitoring of Cognitive Impairment in Individuals electronic self administered gerocognitive examination (eSAGE) - Dementia, Alzheimer Disease | Enrolling by invitation | Douglas Scharre | 1486 | 2024-09-01 | 2026-06-15 | |
| Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease DaTscan, F18-AV-45, FDG-PET - Alzheimer's Disease, Lewy Body Dementia | Recruiting | Douglas Scharre | 76 | 2018-08-30 | 2026-10-15 |
Alzheimer Disease (2) · Cognitive Dysfunction (1) · Dementia (1) · Lewy Body Disease (1) · Parkinson Disease (1)
florbetapir (1) · ioflupane (1)
United States (2)